37.17
price down icon1.59%   -0.60
 
loading
Zai Lab Limited Adr stock is traded at $37.17, with a volume of 635.73K. It is down -1.59% in the last 24 hours and up +0.57% over the past month. Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
See More
Previous Close:
$37.77
Open:
$36.8
24h Volume:
635.73K
Relative Volume:
0.73
Market Cap:
$4.13B
Revenue:
$418.33M
Net Income/Loss:
$-252.07M
P/E Ratio:
-15.49
EPS:
-2.4
Net Cash Flow:
$-238.84M
1W Performance:
+10.72%
1M Performance:
+0.57%
6M Performance:
+41.49%
1Y Performance:
+96.98%
1-Day Range:
Value
$36.51
$37.53
1-Week Range:
Value
$34.54
$38.77
52-Week Range:
Value
$16.01
$44.34

Zai Lab Limited Adr Stock (ZLAB) Company Profile

Name
Name
Zai Lab Limited Adr
Name
Phone
862161632588
Name
Address
4560 JINKE ROAD, SHANGHAI
Name
Employee
1,844
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
ZLAB's Discussions on Twitter

Compare ZLAB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ZLAB
Zai Lab Limited Adr
37.17 4.17B 418.33M -252.07M -238.84M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-07-25 Initiated Scotiabank Sector Outperform
Mar-03-25 Downgrade BofA Securities Buy → Neutral
Dec-14-23 Initiated Morgan Stanley Overweight
Aug-10-23 Initiated Cantor Fitzgerald Overweight
Jan-21-22 Initiated Macquarie Outperform
Oct-12-21 Initiated Bernstein Mkt Perform
Apr-28-20 Initiated Goldman Buy
Apr-15-20 Initiated Guggenheim Buy
Jul-12-19 Initiated BofA/Merrill Buy
Jul-05-19 Initiated Macquarie Outperform
Jan-29-19 Initiated Credit Suisse Outperform
Nov-21-18 Initiated Jefferies Buy
Jun-21-18 Resumed Leerink Partners Outperform
Feb-14-18 Upgrade JP Morgan Neutral → Overweight
Oct-16-17 Initiated JP Morgan Neutral
Oct-16-17 Initiated Leerink Partners Outperform
View All

Zai Lab Limited Adr Stock (ZLAB) Latest News

pulisher
03:34 AM

Cerity Partners LLC Makes New $420,000 Investment in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) - Defense World

03:34 AM
pulisher
03:34 AM

Franklin FTSE Japan ETF (NYSEARCA:FLJP) Position Cut by Cerity Partners LLC - Defense World

03:34 AM
pulisher
03:34 AM

Cerity Partners LLC Takes Position in KANZHUN LIMITED Sponsored ADR (NASDAQ:BZ) - Defense World

03:34 AM
pulisher
03:34 AM

Cerity Partners LLC Purchases Shares of 19,622 Gold Fields Limited (NYSE:GFI) - Defense World

03:34 AM
pulisher
03:32 AM

Envestnet Asset Management Inc. Raises Stock Position in First Trust Intermediate Government Opportunities ETF (NYSEARCA:MGOV) - Defense World

03:32 AM
pulisher
Jul 25, 2025

Zai Lab Limited's (NASDAQ:ZLAB) large institutional owners must be happy as stock continues to impress, up 4.9% over the past week - simplywall.st

Jul 25, 2025
pulisher
Jul 24, 2025

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Shares Acquired by Envestnet Asset Management Inc. - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

Knorr-Bremse (KNRRY) Expected to Announce Quarterly Earnings on Thursday - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

Ero Copper (ERO) Expected to Announce Quarterly Earnings on Thursday - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

Standard Chartered (SCBFY) Projected to Post Earnings on Thursday - Defense World

Jul 24, 2025
pulisher
Jul 16, 2025

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities - Benzinga

Jul 16, 2025
pulisher
Jul 16, 2025

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities16.07.25News - Ariva

Jul 16, 2025
pulisher
Jul 15, 2025

M&T Bank Corp Reduces Stock Holdings in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) - Defense World

Jul 15, 2025
pulisher
Jul 10, 2025

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025 - Business Wire

Jul 10, 2025
pulisher
Jul 03, 2025

Leerink Partnrs Issues Positive Outlook for Zai Lab Earnings - Defense World

Jul 03, 2025
pulisher
Jun 30, 2025

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer - Business Wire

Jun 30, 2025
pulisher
Jun 26, 2025

Cantor Fitzgerald Expects Reduced Earnings for Zai Lab - Defense World

Jun 26, 2025
pulisher
Jun 20, 2025

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis - Yahoo Finance

Jun 20, 2025
pulisher
Jun 18, 2025

Metric Deep Dive: Understanding Winnebago Industries, Inc (WGO) Through its Ratios - DWinneX

Jun 18, 2025
pulisher
Jun 18, 2025

Zai Lab Limited ADR (ZLAB) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jun 18, 2025
pulisher
Jun 18, 2025

10 Biotech Stocks Screaming a Buy - Insider Monkey

Jun 18, 2025
pulisher
Jun 16, 2025

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st

Jun 16, 2025
pulisher
Jun 13, 2025

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025 - Business Wire

Jun 13, 2025
pulisher
Jun 12, 2025

Zai Lab Limited ADR (ZLAB) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jun 12, 2025
pulisher
Jun 12, 2025

CarParts.com Inc (PRTS) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jun 12, 2025
pulisher
Jun 11, 2025

Yatsen And Zai Lab Shine As Asian ADRs Climb In The US - Finimize

Jun 11, 2025
pulisher
Jun 09, 2025

Zai Lab Limited (NASDAQ:ZLAB) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Trims Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Boosts Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Bank of America Corp DE Has $1.63 Million Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLA - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial - MSN

Jun 05, 2025
pulisher
Jun 02, 2025

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting - Business Wire

Jun 02, 2025
pulisher
Jun 01, 2025

Zai Lab Limited (NASDAQ:ZLAB) Sees Large Drop in Short Interest - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Yahoo Finance

May 31, 2025
pulisher
May 31, 2025

What Analysts Were Expecting After Zai Lab Limited ADR (NASDAQ: ZLAB) fell -3.74% - Stocksregister

May 31, 2025
pulisher
May 30, 2025

Zai Lab Announces Participation in Investor Conferences in June 2025 - BioSpace

May 30, 2025
pulisher
May 30, 2025

Zai Lab Lines Up Triple Conference Presence: Jefferies, Goldman Sachs, and Scotiabank Healthcare Events - Stock Titan

May 30, 2025
pulisher
May 30, 2025

Upper Peninsula ABC 10News, Sports, Weather and More from Michigan's Upper Peninsula - FinancialContent

May 30, 2025
pulisher
May 28, 2025

Northern Trust Corp Increases Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 28, 2025
pulisher
May 27, 2025

Quantinno Capital Management LP Reduces Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 27, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Purchases 18,472 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 25, 2025
pulisher
May 19, 2025

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer - BioSpace

May 19, 2025
pulisher
May 15, 2025

Barclays PLC Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald Expects Increased Earnings for Zai Lab - Defense World

May 15, 2025
pulisher
May 13, 2025

Zai Lab Limited (NASDAQ:ZLAB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 11, 2025

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - MSN

May 11, 2025
pulisher
May 09, 2025

Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight - GuruFocus

May 09, 2025
pulisher
May 07, 2025

Trading Day Triumph: Zai Lab Limited ADR (ZLAB) Ends at 29.38, a -5.07 Surge/Plunge - DWinneX

May 07, 2025
pulisher
May 05, 2025

Raymond James Financial Inc. Makes New $1.03 Million Investment in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 05, 2025
pulisher
May 02, 2025

Zai Lab Limited (NASDAQ:ZLAB) Shares Bought by Invesco Ltd. - Defense World

May 02, 2025

Zai Lab Limited Adr Stock (ZLAB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):